Cargando…
Perspectives of Ketamine Use in COVID-19 Patients
Hospitalized coronavirus disease 2019 (COVID-19)-infected patients suffer from both physical impairments and mental stress. Respiratory insufficiency and cardiovascular disturbances require most of the intensive care interventions, but they are also accompanied by depressive conditions, sadness and...
Autor principal: | Weinbroum, Avi A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834903/ https://www.ncbi.nlm.nih.gov/pubmed/33496087 http://dx.doi.org/10.3346/jkms.2021.36.e28 |
Ejemplares similares
-
Oral ketamine for phantom limb pain: An option for challenging cases
por: Mitra, Sukanya, et al.
Publicado: (2015) -
Fentanyl or ketamine pre-treatment to prevent withdrawal response to rocuronium
por: Kosare, Suchita S, et al.
Publicado: (2017) -
Patient and Provider Perspectives on Pediatric Telemedicine During the COVID-19 Pandemic
por: Katz, Sophie E., et al.
Publicado: (2021) -
Impact of COVID-19 pandemic on pediatric patients with epilepsy – The caregiver perspective
por: Trivisano, Marina, et al.
Publicado: (2020) -
Midazolam premedication for Ketamine-induced emergence phenomenon: A prospective observational study
por: Perumal, Deepa Kameswari, et al.
Publicado: (2015)